Leight S[au] - Search Results

Year	Number of Results
1995	2
1997	3
1998	2
1999	1
2000	1
2001	1
2002	2
2003	2
2005	2
2006	1
2007	4
2008	6
2010	1
2011	1
2012	1
2017	1
2018	1
2019	1
2020	1
2022	0

1

Biomarkers for early detection of Alzheimer pathology.

Clark CM, Davatzikos C, Borthakur A, Newberg A, Leight S, Lee VM, Trojanowski JQ. Clark CM, et al. Among authors: leight s. Neurosignals. 2008;16(1):11-8. doi: 10.1159/000109754. Epub 2007 Dec 5. Neurosignals. 2008. PMID: 18097155 Free PMC article. Review.

2

Conformation-selective tau monoclonal antibodies inhibit tau pathology in primary neurons and a mouse model of Alzheimer's disease.

Gibbons GS, Kim SJ, Wu Q, Riddle DM, Leight SN, Changolkar L, Xu H, Meymand ES, O'Reilly M, Zhang B, Brunden KR, Trojanowski JQ, Lee VMY. Gibbons GS, et al. Among authors: leight sn. Mol Neurodegener. 2020 Nov 4;15(1):64. doi: 10.1186/s13024-020-00404-5. Mol Neurodegener. 2020. PMID: 33148293 Free PMC article.

3

Starry night: using story to inform aesthetic knowing in women's health nursing.

Leight SB. Leight SB. J Adv Nurs. 2002 Jan;37(1):108-14. doi: 10.1046/j.1365-2648.2002.02050.x. J Adv Nurs. 2002. PMID: 11784404 Review.

4

The application of a vulnerable populations conceptual model to rural health.

Leight SB. Leight SB. Public Health Nurs. 2003 Nov-Dec;20(6):440-8. doi: 10.1046/j.1525-1446.2003.20604.x. Public Health Nurs. 2003. PMID: 14629675 Review.

5

Stereotaxic Targeting of Alpha-Synuclein Pathology in Mouse Brain Using Preformed Fibrils.

Zhang B, Kehm V, Gathagan R, Leight SN, Trojanowski JQ, Lee VM, Luk KC. Zhang B, et al. Among authors: leight sn. Methods Mol Biol. 2019;1948:45-57. doi: 10.1007/978-1-4939-9124-2_5. Methods Mol Biol. 2019. PMID: 30771169 Free PMC article.

6

Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.

Gibbons GS, Banks RA, Kim B, Changolkar L, Riddle DM, Leight SN, Irwin DJ, Trojanowski JQ, Lee VMY. Gibbons GS, et al. Among authors: leight sn. J Neuropathol Exp Neurol. 2018 Mar 1;77(3):216-228. doi: 10.1093/jnen/nly010. J Neuropathol Exp Neurol. 2018. PMID: 29415231 Free PMC article.

7

Comparison of xMAP and ELISA assays for detecting cerebrospinal fluid biomarkers of Alzheimer's disease.

Wang LS, Leung YY, Chang SK, Leight S, Knapik-Czajka M, Baek Y, Shaw LM, Lee VM, Trojanowski JQ, Clark CM. Wang LS, et al. Among authors: leight s. J Alzheimers Dis. 2012;31(2):439-45. doi: 10.3233/JAD-2012-120082. J Alzheimers Dis. 2012. PMID: 22571982 Free PMC article.

8

GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.

Gibbons GS, Banks RA, Kim B, Xu H, Changolkar L, Leight SN, Riddle DM, Li C, Gathagan RJ, Brown HJ, Zhang B, Trojanowski JQ, Lee VM. Gibbons GS, et al. Among authors: leight sn. J Neurosci. 2017 Nov 22;37(47):11485-11494. doi: 10.1523/JNEUROSCI.2393-17.2017. Epub 2017 Oct 6. J Neurosci. 2017. PMID: 28986461 Free PMC article.

9

Cerebrospinal fluid profile in frontotemporal dementia and Alzheimer's disease.

Grossman M, Farmer J, Leight S, Work M, Moore P, Van Deerlin V, Pratico D, Clark CM, Coslett HB, Chatterjee A, Gee J, Trojanowski JQ, Lee VM. Grossman M, et al. Among authors: leight s. Ann Neurol. 2005 May;57(5):721-9. doi: 10.1002/ana.20477. Ann Neurol. 2005. PMID: 15852395

10

Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration.

Gao HM, Kotzbauer PT, Uryu K, Leight S, Trojanowski JQ, Lee VM. Gao HM, et al. Among authors: leight s. J Neurosci. 2008 Jul 23;28(30):7687-98. doi: 10.1523/JNEUROSCI.0143-07.2008. J Neurosci. 2008. PMID: 18650345 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results